Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics. The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin. Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID.
On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.
Ibuprofen is the most commonly used and prescribed NSAID. It is a very common over-the-counter medication widely used as an analgesic, anti-inflammatory and antipyretic.
The use of ibuprofen and its enantiomer Dexibuprofen in a racemic mix is common for the management of mild to moderate pain related to dysmenorrhea, headache, migraine, postoperative dental pain, spondylitis, osteoarthritis, rheumatoid arthritis, and soft tissue disorder.
Due to its activity against prostaglandin and thromboxane synthesis, ibuprofen has been attributed to alteration of platelet function and prolongation of gestation and labour.
As ibuprofen is a widely used medication, the main therapeutic indications are:
University of Mississippi Medical Center, Jackson, Mississippi, United States
Children's Medical Center Dallas, Dallas, Texas, United States
Baylor College of Medicine/Texas Children's Hospital, Houston, Texas, United States
Assiut university, Assiut, Egypt
Department of Obstetrics and Gynecology, Bern University Hospital, Bern, Switzerland
Karolinska Institutet, Stockholm, Sweden
Quotient Clinical Ltd, Nottingham, Notts, United Kingdom
University of Minnesota, Minneapolis, Minnesota, United States
Laureate Institute for Brain Research, Tulsa, Oklahoma, United States
CROSS Research S.A., Phase I Unit, Via F.A. Giorgioli 14 Phone: Fax: +41.91.63.00.511 Email:, Arzo, Switzerland
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.